Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial
S von Haehling, JC Schefold, EA Jankowska… - Journal of the American …, 2012 - jacc.org
Objectives: This study sought to assess the effects of ursodeoxycholic acid (UDCA) on
endothelial function and inflammatory markers in patients with chronic heart failure (CHF) …
endothelial function and inflammatory markers in patients with chronic heart failure (CHF) …
Bile acids for liver‐transplanted patients
Background Liver transplantation has become a widely accepted form of treatment for
numerous end‐stage liver diseases. Bile acids may decrease allograft rejection after liver …
numerous end‐stage liver diseases. Bile acids may decrease allograft rejection after liver …
Ursodeoxycholic acid increased bile flow and affects bile composition in the early postoperative phase following liver transplantation
G Söderdahl, G Nowak, F Duraj, FH Wang… - Transplant …, 1998 - Wiley Online Library
Orally given ursodeoxycholic acid (UDCA) has beneficial effects on laboratory parameters in
different cholestatic conditions. In order to investigate the effect on early graft function after …
different cholestatic conditions. In order to investigate the effect on early graft function after …
Efficacy of ursodeoxycholic acid as an adjuvant treatment to prevent acute cellular rejection after liver transplantation: a meta-analysis of randomized controlled trials
YL Deng, XZ Xiong, NS Cheng - Hepatobiliary & Pancreatic Diseases …, 2014 - Elsevier
Background Acute cellular rejection (ACR) after liver transplantation (LT) is one of the most
common problems faced by transplant recipients in spite of advances in immunosuppressive …
common problems faced by transplant recipients in spite of advances in immunosuppressive …
[PDF][PDF] Exploring Novel Applications for Ursodeoxycholic Acid in the Treatment of Cardiovascular Conditions
O Adeyemi - 2016 - core.ac.uk
As a bile acid, ursodeoxycholic acid (UDCA) is found endogenously formed in humans and
other mammals where it is primarily involved in lipid metabolism. It is approved under a …
other mammals where it is primarily involved in lipid metabolism. It is approved under a …
Эффект урсодеоксихолевой кислоты у больных хронической сердечной недостаточностью. Двойное слепое рандомизированное плацебо-контролируемое …
S Von Haehling, JC Schefold… - Рациональная …, 2012 - cyberleninka.ru
Цель. Оценить влияние урсодеоксихолевой кислоты (УДХК) на функцию эндотелия и
маркеры воспаления у больных хронической сердечной недостаточностью (ХСН) …
маркеры воспаления у больных хронической сердечной недостаточностью (ХСН) …
Old and new immunosuppressant drugs: mechanisms and potential value
JM Vierling - Primary Biliary Cirrhosis: From Pathogenesis to Clinical …, 1998 - Springer
Primary biliary cirrhosis (PBC) is a chronic, progressive cholestatic liver disease that
predominantly affects women. It is characterized by inflammatory destruction of interlobular …
predominantly affects women. It is characterized by inflammatory destruction of interlobular …
[PDF][PDF] Tyramine Hydrochloride⊗
ATC Vet—QC01EB09 - Lancet, 1994 - drugfuture.com
Tyramine hydrochloride is a sympathomimetic with indirect effects on adrenergic receptors. It
has been given orally or by injection in the tyramine pressor test for the investigation of …
has been given orally or by injection in the tyramine pressor test for the investigation of …
[引用][C] URSODEOXYCHOLIC ACID IN PATIENTS WITH CHRONIC HEART FAILURE. A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER …
S von Haehling, JC Schefold, EA Jankowska… - Rational Pharmacotherapy …, 2015